Development of a new antioxidant therapy for sepsis using DHLH-Zn, a novel alpha-lipoic acid
Development of a new antioxidant therapy for sepsis using DHLH-Zn, a novel alpha-lipoic acid
批准号:
23792076
负责人:
KOGA HIRONORI
金额:
$2.66万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Young Scientists (B)
财政年份:
2011
资助国家:
日本
项目状态:
已结题
起止时间:
2011 至 2013
中文摘要
点击翻译按钮获取中文摘要
英文摘要
We investigated whether Sodium Zinc Histidine Dithiooctanamide (DHLH-Zn), a novel alpha-lipoic acid derivative, had therapeutic effect against sepsis. The results of the present study indicated that DHLH-Zn ameliorated sepsis-induced organ damage by suppression of oxidative stress in rat model. In addition, we tried to clarify the mechanism of antioxidative effect. We attempted to establish the assessment method of oxidative steress in some biotic samples with the use of electron spin resonance (ESR) apparatus. It was hard to measure the oxidative steress directly because of various interfering factors in samples, however, we improved the accuracy of measurement after careful consideration.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of a cerebroprotective agent with ETS-GS, a novel antioxidant
-
批准号:26462366
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.08万
-
财政年份:2014
-
负责人:KOGA HIRONORI
-
依托单位:
海外基金